StonvexLoading…
StonvexStonvexStonvexCore line items from SRXH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.25M | $2.81M | $6.53M | $41.08M |
Operating Income | $-5.61M | $-3.79M | $-11.41M | $-32.18M |
Net Income | $-14.99M | $-8.61M | $-45.01M | $-29.75M |
EPS (Diluted) | $-0.09 | $-0.26 | $-2.13 | $-1.54 |
Total Assets | $43.36M | $27.05M | $8.40M | $33.98M |
Total Liabilities | $25.08M | $23.53M | $8.00M | $79.86M |
Cash & Equivalents | $20.54M | $13.06M | $1.31M | $912.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 415.96M | 98.76M | 24.99M | 15.16M |